Velara Labs · device architecture

Dual-chamber technology

Separated until activation. Designed for stability.

A clear device architecture designed to keep liquid and lyophilized components separated until preparation according to the product’s intended process.

Velara Labs dual-chamber Retatrutide pen cutaway

Five-step architecture

A considered preparation concept.

The following sequence explains the intended device concept shown in the official cutaway. It is not a dosing or use instruction.

Step 01

Liquid chamber

Liquid component held in the upper chamber.

Step 02

Separation

A movable stopper separates the two components.

Step 03

Activation

Activation brings the separated components together according to the intended preparation process.

Step 04

Mixing

The architecture supports an on-demand mixing concept.

Step 05

Ready for research

Completed pen architecture in a precision research format.

Official Velara Labs dual-chamber mechanism diagram
Official Velara Labs dual-chamber mechanism diagram

Interactive pen mechanism

Inspect the device architecture.

Select any labeled component to reveal a concise explanation grounded in the supplied mechanism diagram.

Selected component

Liquid chamber

The upper chamber contains the liquid component, kept separate from the lyophilized component before intended activation or preparation.

Selected component

Liquid chamber

The upper chamber contains the liquid component, kept separate from the lyophilized component before intended activation or preparation.

LOOPING MECHANISM VISUAL

Watch the transfer pathway.

A continuous technical loop illustrating chamber separation, controlled transfer and the prepared research state. Architectural overview only; not a dosing or use instruction.

Velara Labs device animation placeholder using official mechanism asset

CONTINUOUS LOOP

DEVICE PROCESS OVERVIEW

How the mechanism progresses.

A three-part reference to the dual-chamber architecture shown above.

STEP 01

Separated by design

The liquid and lyophilized chambers remain isolated before the intended activation process.

STEP 02

Controlled transfer

As the internal stopper advances, liquid follows the internal bypass pathway toward the second chamber.

STEP 03

Prepared research state

The architecture is designed to support on-demand combination within the specified research workflow.

ARCHITECTURE ONLY

This visual describes device architecture for research context. Consult the applicable product documentation for any approved process.